Send Inquiry

Request To Call Back

ERLONAT ERLOTINIB TABLETS 150 MG

Get a Price/Quote

ERLONAT ERLOTINIB TABLETS 150 MG Specification

Pacakaging (Quantity Per Box)
30 Tablets

Origin of Medicine
India

Salt Composition
Erlotinib 150 mg

Indication
EGFR Mutation-Positive Non-Small Cell Lung Cancer, Pancreatic Cancer

Dosage Form
Tablet

Drug Type
Targeted Therapy

Ingredients
Erlotinib Hydrochloride

Physical Form
Tablets

Function
Anti-Cancer

Recommended For
Non-Small Cell Lung Cancer, Pancreatic Cancer

Dosage
As directed by physician

Dosage Guidelines
Take orally, do not crush or chew, preferably on an empty stomach

Suitable For
Adults

Quantity
30 Tablets per Box

Storage Instructions
Store below 30C, protect from light and moisture

Appearance
White to off-white round tablets, film-coated

Availability
Hospital supply, pharmacies, online order

ATC Code
L01XE03

Route of Administration
Oral

Therapeutic Class
Antineoplastic agents

MRP
As per label

Contraindications
Hypersensitivity to erlotinib or any ingredients in the formulation

Side Effects
Rash, diarrhea, loss of appetite, fatigue, shortness of breath

Brand Name
Erlonat

Batch Number
As per packaging

International Shipping
Available

Expiry Period
24 months from manufacture date

Prescription/Non Prescription
Prescription

ERLONAT ERLOTINIB TABLETS 150 MG Trade Information

Packaging Details
PACK OF 30 TABLETS

About ERLONAT ERLOTINIB TABLETS 150 MG

Product Name - Erlonat 150 Mg Tablets

Specification

Content - Erlotinib Hydrochloride
Form - Tablets
Strength - 25 Mg, 100Mg, 150 Mg
Packing - Pack Of 30 Tablets
Manufactured By : Natco

Note :- Erlonat Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug...............

Targeted Therapy for Cancer

Erlonat Erlotinib 150 mg functions as a highly specific targeted therapy designed to block the growth of cancer cells in adults with certain types of lung and pancreatic cancers. Its primary benefit lies in treating EGFR mutation-positive non-small cell lung cancer and advanced pancreatic cancer, offering a tailored approach that aims to minimize damage to healthy cells. This therapy is a vital part of modern oncological care and supports improved outcomes for eligible patients.

Proper Usage and Administration

Erlonat tablets are intended for oral administration as directed by a physician. For optimal absorption and efficacy, the medication should be taken on an empty stomach, at least one hour before or two hours after eating. The tablets must not be crushed or chewed. Dosage varies based on individual medical conditions and response to therapy. Patients are strongly advised to follow their healthcare providers instructions and never adjust their dose independently.

Storage and Handling Guidelines

For maximum efficacy, Erlonat 150 mg tablets must be stored below 30C and protected from light and moisture. Each box holds 30 tablets, with packaging details and batch number clearly marked. Always keep the medication in its original packaging to preserve its integrity, and ensure it is out of reach of children. Initiate each new supply only after checking the expiry date and batch details on the label, given the 24-month shelf life from manufacturing.

FAQs of ERLONAT ERLOTINIB TABLETS 150 MG:

Q: How should Erlonat Erlotinib 150 mg tablets be taken for best results?

A: Erlonat tablets should be swallowed whole with water, taken on an empty stomachat least one hour before or two hours after eating. Follow your doctors specific dosage instructions and do not crush or chew the tablets.

Q: What types of cancer is Erlonat indicated for?

A: Erlonat is indicated for the treatment of EGFR mutation-positive non-small cell lung cancer and advanced pancreatic cancer in adult patients, as determined by your physician.

Q: When should I avoid taking Erlonat Erlotinib tablets?

A: You should avoid taking Erlonat if you have a known hypersensitivity to erlotinib or any ingredients in the formulation. Inform your doctor of any allergies or prior adverse reactions before starting therapy.

Q: Where can I obtain Erlonat Erlotinib 150 mg tablets?

A: Erlonat is available via hospital pharmacies, authorized retail pharmacies, and select online platforms, with the option for international shipping in accordance with prescription requirements.

Q: What side effects should I watch for while using Erlonat?

A: Common side effects include rash, diarrhea, loss of appetite, fatigue, and shortness of breath. Contact your healthcare provider if these symptoms are severe or persistent, or if you experience any unusual reactions.

Q: What are the storage requirements for Erlonat tablets?

A: Store Erlonat below 30C, away from light and moisture, and in the original packaging. Check the expiry date and batch number before use and keep the medication out of reach of children.

Q: How does Erlonat benefit patients with cancer?

A: Erlonat provides a targeted approach to inhibiting cancer cell growth in specific types of lung and pancreatic cancer, contributing to better disease management with tailored therapy based on genetic mutations.

Tell us about your requirement